PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026Lishizhen medicine and materia medica research0 citations

Radix Astragali-Rhizoma Coptidis medicinal couplet alleviates hepatic fat deposition in rats with impaired glucose tolerance via the Keap1/Nrf2/GPX4 pathway

View Full Paper
RZRuihe ZhuWDWenjie DAIRXRui Xu

Key Points

  • The study aims to explore how the Radix Astragali-Rhizoma Coptidis couple influences liver fat deposition via the Keap1/Nrf2/GPX4 pathway in rats with impaired glucose tolerance.
  • Used male Wistar rats on a high-fat, high-sugar diet to create an impaired glucose tolerance model.
  • Divided rats into three groups: control, Radix Astragali-Rhizoma Coptidis treated, and metformin treated.
  • Administered interventions for four weeks and assessed general condition, blood glucose, and liver morphology.
  • Measured protein and mRNA levels of Keap1, Nrf2, HO-1, and GPX4 in liver tissues using immunofluorescence and qPCR.
  • The herbal treatment significantly reduced blood glucose levels during the OGTT in the treated group (P<0.05).
  • It decreased liver fat vacuolation and downregulated Keap1 protein and mRNA expression.
  • Nrf2 protein levels increased, along with the mRNA levels of Nrf2, GPX4, and HO-1, all statistically significant (P<0.05).

Abstract

目的 探讨黄芪-黄连药对可能通过Keap1/Nrf2/GPX4通路来降低糖耐量减低大鼠(IGT)肝脏脂肪沉积的潜在作用机制。 方法 SPF级雄性Wistar大鼠,随机挑选10只作为空白组,余给予高糖高脂饮食10周和小剂量链脲佐菌素复制IGT模型,分为模型组(n=9)、黄芪-黄连药对组(4.05 g·kg-1·d-1,n=10)、二甲双胍组(0.05 g·kg-1·d-1,n=9)。干预4周,观察各组一般情况、血糖相关指标改变;HE染色观察肝脏组织形态;免疫荧光染色与qPCR检测肝脏组织Keap1、Nrf2、HO-1、GPX4蛋白、mRNA含量。 结果 干预后,黄芪-黄连可降低OGTT试验2h血糖(PP 结论 黄芪-黄连药对可有效降低IGT大鼠血糖和肝脏脂肪空泡形态,其机制可能与调控Keap1/Nrf2/GPX4信号通路有关。

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhu et al. (2026) studied this question.

synapsesocial.com/papers/69aa7160531e4c4a9ff5b7fdhttps://doi.org/10.70976/j.1008-0805.szgygy-2026-0110
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mechanism of ligustrazine in alleviating biliary atresia-associated liver fibrosis by regulating the TGF-β/Smad pathway and inhibiting hepatocyte pyroptosis2026
  2. 2Mechanism of electroacupuncture in improving lipid metabolism in diabetic cardiomyopathy mice via activation of the intestinal FXR/FGF15 pathway2026
  3. 3Mechanism of Atractylodin in inhibiting JS-1 hepatic stellate cell activation via regulation of unsaturated fatty acid metabolism2026
  4. 4Mechanistic study of Bazhen Lihe Kangxian Formula (八珍荔核抗纤方) on CCl₄-induced liver fibrosis in rats via the COX-2/PGE₂/NF-κB signaling pathway2026
  5. 5Exploring the Mechanism of Action of the Rhubarb-Gardenia Couplet in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Bioinformatics2025